Development of a Global Manufacturing and Sales Structure

「<Basic Strategies>\n① Build global marketing capabilities\n② Accelerate global expansion and achieve growth with an awareness of the business portfolio\n③ Strengthen R&D and production capabilities that support business growth\n④ Operate business portfolio management\n⑤ Implement sustainability management that adapts to changes in the business environment」

「Going forward, taking into account geopolitical risks and the impact of US tariffs, the Company aims to expand performance by expanding its sales areas and distribution network, improving productivity, and optimising production.」

「The Group consists of the Company, 21 subsidiaries and 1 affiliated company, and its principal business activities are the manufacture and sale of semiconductor-related equipment, medical and healthcare equipment, and measurement and weighing equipment.」

「Meanwhile, in the medical and healthcare equipment business, revenue and profit both declined year on year due largely to varying demand by customer and region and the impact of foreign exchange. The measurement and weighing equipment business also reported year-on-year declines in both revenue and profit, largely due to the particularly significant impact of weak overseas capital investment demand.」

「In the medical and healthcare equipment business, revenue declined year on year due largely to the impact of foreign exchange, but profit increased year on year as the company continued efforts to reduce costs and control selling, general and administrative expenses. Meanwhile, the measurement and weighing equipment business reported year-on-year declines in both revenue and profit, largely due to the particularly significant impact of weak overseas capital investment demand.」

「In the Americas, demand for household blood pressure monitors in the United States remained strong, and sales increased, mainly on large-scale projects. Profit also increased due to lower transportation costs and the product mix.」

「The measurement and weighing equipment business performed steadily against a backdrop of global economic recovery. In the medical and healthcare equipment business, although consumer purchasing sentiment was weakening amid concerns about global inflation, particularly in the Americas, sales in local-currency terms remained at approximately the previous fiscal year's level, mainly in Japan and the Americas. In addition, the weaker yen increased sales in yen terms in both businesses. The semiconductor-related business, added as a segment in connection with the Group's reorganization, recorded higher sales and profit, supported by strong orders since the previous fiscal year.」

「In Asia and Oceania, sales and profit increased as sales of weighing equipment in South Korea and metal detectors and weight checkers in India grew substantially, while demand for other products and in other regions also began to recover.」

「In Europe, expenses increased due to higher transportation costs, but sales grew as the sales network for weighing equipment was strengthened, allowing profit to remain at approximately the same level as in the same period of the previous year.」

「In Asia and Oceania, sales increased as sales of weighing equipment, including metal detectors and weight checkers in Australia, grew, while in South Korea and India restrictions on sales activities imposed by the spread of COVID-19 were gradually eased. As a result, the business entered a recovery trend from the third quarter of the current consolidated fiscal year. In addition, sales from the Taiwanese subsidiary, A&D SCIENTECH TAIWAN LIMITED, which became a subsidiary in the fourth quarter of the previous consolidated fiscal year, contributed to the year-on-year increases in sales and profit.」

「In the Americas, sales remained sluggish due to the impact of COVID-19, but returned to profitability as a result of efforts to reduce expenses.」

「Our Group produces and sells measurement and weighing equipment and medical and healthcare equipment. In Japan, the Company and its subsidiaries are responsible for these operations, while overseas subsidiaries are responsible for the respective regions: the Americas (the United States and Canada), Europe (the United Kingdom, Germany and Russia), and Asia and Oceania (China, South Korea, India, Australia and other countries).」

「In the Americas, sales increased substantially as shipments for large-scale projects continued in the United States and sales of blood glucose meters and other products were strong in Canada.」

「In Asia and Oceania, metal detectors and weight checkers in Australia continued to perform well from the previous consolidated fiscal year and sales increased in local-currency terms. However, sales declined because the yen remained stronger year on year and the special demand seen in South Korea in the same period of the previous year had subsided.」

「Our Group produces and sells measurement and weighing equipment and medical and healthcare equipment. In Japan, the Company and its subsidiaries are responsible for these operations, while overseas subsidiaries are responsible for the respective regions: the Americas (the United States and Canada), Europe (the United Kingdom, Germany and Russia), and Asia and Oceania (China, South Korea, India, Australia and Vietnam).」

「Our Group produces and sells measurement and weighing equipment and medical and healthcare equipment. In Japan, the Company and its subsidiaries are responsible for these operations, while overseas subsidiaries are responsible for the respective regions: the Americas (the United States and Canada), Europe (the United Kingdom, Germany and Russia), and Asia and Oceania (China, South Korea, India, Australia and Vietnam).」

「In Asia and Oceania, sales of weighing equipment increased, supported by strong performance in South Korea of high-precision weighing sensors for integration into production lines and other products, while sales of measurement equipment increased due in part to orders for large-scale testing machines in China.」

「In Asia and Oceania, sales increased as high-precision weighing sensors for integration into production lines and other products performed well in South Korea, while metal detectors and weight checkers performed well in India. In Australia, metal detectors and weight checkers also performed steadily, supported by strengthened promotional activities including participation in trade shows.」

「In the Americas, sales of weighing equipment were at approximately the same level as in the same period of the previous year. However, sales of DSP systems recovered as the effects of the previously undertaken review of the sales structure began to emerge, supported by gradual economic expansion.」

「Our Group produces and sells measurement and weighing equipment and medical and healthcare equipment. In Japan, the Company and its subsidiaries are responsible for these operations, while overseas subsidiaries are responsible for the respective regions: the Americas (the United States and Canada), Europe (the United Kingdom, Germany and Russia), and Asia and Oceania (China, South Korea, India, Australia and Vietnam).」

「In the Americas, sales increased as revenue from the Canadian subsidiary established in the previous consolidated fiscal year was added.」

「In the Americas, sales increased as revenue from the Canadian subsidiary established in the previous consolidated fiscal year was added.」

「In the Americas, sales increased as revenue from the Canadian subsidiary established in the previous consolidated fiscal year was added.」

「As a global operator in production and sales, we are implementing measures to improve resilience to exchange-rate fluctuations by, in principle, compressing foreign-currency-denominated receivables and payables at overseas subsidiaries to within 1 month of sales, thereby reducing foreign exchange risk arising from volatility in exchange rates attributable to fluctuations in crude oil prices and events such as the China shock in recent years.」